Laboratory News and Research

RSS

Phase 2 clinical study examines Alzheimer's disease drug to treat adults with Down syndrome

A phase 2 clinical trial in young adults with Down syndrome of a drug being investigated for the treatment of Alzheimer's disease supports further investigation of its potential.

1 Jun 2017

Scientists identify novel microbial process that can break down toxic methylmercury levels

A team led by the Department of Energy's Oak Ridge National Laboratory has identified a novel microbial process that can break down toxic methylmercury in the environment, a fundamental scientific discovery that could potentially reduce mercury toxicity levels and support health and risk assessments.

1 Jun 2017

Brain's immune cells may play roles in neurodegenerative, psychiatric illnesses

Scientists have, for the first time, characterized the molecular markers that make the brain's front lines of immune defense--cells called microglia--unique.

31 May 2017

Duke University researchers develop handheld device for easier cervical cancer screening

Duke University researchers have developed a handheld device for cervical cancer screening that promises to do away with uncomfortable speculums and high-cost colposcopes.

31 May 2017

MIT researchers develop new navigation system for visually impaired people

Computer scientists have been working for decades on automatic navigation systems to aid the visually impaired, but it's been difficult to come up with anything as reliable and easy to use as the white cane, the type of metal-tipped cane that visually impaired people frequently use to identify clear walking paths.

31 May 2017

Therapeutic small molecules safely prevent blood clots without excessive bleeding

It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.

31 May 2017

Case Western Reserve University awarded $6 million grant to continue research on Barrett's Esophagus

The National Cancer Institute recently awarded a $6 million grant to the Case Comprehensive Cancer Center and Case Western Reserve University School of Medicine to continue research on Barrett's Esophagus, a potentially fatal condition caused by long-term acid reflux.

31 May 2017

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

Radiation therapy is one of the most common treatments used to fight cancer, with an estimated 500,000 people each year receiving radiation therapy either alone or in combination with other treatments.

31 May 2017

Nitrogen oxide emissions from traffic higher than previously thought

In metropolitan areas throughout Europe maximum permissible values of nitrogen oxide are consistently breached. It has been a challenge to determine how much each polluter contributes to the emission output.

31 May 2017

Sugar sponges could one day serve as treatment for diabetes

Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.

31 May 2017

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

31 May 2017

Real-time imaging of influenza infection in mice can be promising evaluation tool

Real-time imaging of influenza infection in mice is a promising new method to quickly monitor disease progression and to evaluate whether candidate vaccines and treatments are effective in this animal model, according to National Institutes of Health scientists.

31 May 2017

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study results from a small clinical trial led at Fred Hutchinson Cancer Research Center.

31 May 2017

Common, inexpensive chemical could slow aging of human skin, research suggests

New work from the University of Maryland suggests that a common, inexpensive and safe chemical could slow the aging of human skin.

31 May 2017

CRISPR may not be as foolproof as earlier believed – gene editing tech leads to unwanted mutations

CRISPR-Cas9 is a revolutionary new gene-editing technology that has been called “molecular scissors” and has been one of the handiest tools for genetic engineers in the recent times. It makes cutting and pasting gene sequences almost as easy as it sounds. CRISPR has been hailed as a breakthrough in genetic engineering.

30 May 2017

Amped up antibiotic to fight resistant bacteria finally a reality

Resistant bacteria have been a menace killing thousands worldwide. Bacteria causing pneumonia, tuberculosis, wound and skin infections, gonorrhea have notably undergone major changes to evade the current armament of antibiotics that physicians have to fight them with.

30 May 2017

A new Zika threat hovers as summer’s mosquitoes get bzzzzy

Zika, the mosquito-borne virus that triggered public health alarm bells last summer, has receded from the spotlight. But, experts say, expect the virus to pose a renewed threat this year.

30 May 2017

JGU chemists develop technique that reduces toxic effects of cigarettes

Chemists at Johannes Gutenberg University Mainz have developed a technique that reduces the toxic effects of commercially available cigarettes.

30 May 2017

Dual therapy effective as second-line treatment for patients infected by HIV with multiple mutations

ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations.

29 May 2017

Preventative measures can help minimize rising threat of tick-borne illnesses

Healthcare providers and researchers agree: this will be a bad year for ticks and we need use preventative measures to minimize the threat of tick-borne illnesses.

27 May 2017

Laboratory News and Research

Phase 2 clinical study examines Alzheimer's disease drug to treat adults with Down syndrome

Scientists identify novel microbial process that can break down toxic methylmercury levels

Brain's immune cells may play roles in neurodegenerative, psychiatric illnesses

Duke University researchers develop handheld device for easier cervical cancer screening

MIT researchers develop new navigation system for visually impaired people

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Case Western Reserve University awarded $6 million grant to continue research on Barrett's Esophagus

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

Nitrogen oxide emissions from traffic higher than previously thought

Sugar sponges could one day serve as treatment for diabetes

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Real-time imaging of influenza infection in mice can be promising evaluation tool

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Common, inexpensive chemical could slow aging of human skin, research suggests

CRISPR may not be as foolproof as earlier believed – gene editing tech leads to unwanted mutations

Amped up antibiotic to fight resistant bacteria finally a reality

A new Zika threat hovers as summer’s mosquitoes get bzzzzy

JGU chemists develop technique that reduces toxic effects of cigarettes

Dual therapy effective as second-line treatment for patients infected by HIV with multiple mutations

Preventative measures can help minimize rising threat of tick-borne illnesses

Lab Diagnostics and Automation - Second Edition eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest Life Science News